Human papillomavirus vaccine impact on invasive cervical cancer in Japan: Preliminary results from cancer statistics and the MINT study

The first prophylactic vaccine against human papillomavirus (HPV) 16 and HPV18 was licensed in Japan in 2009. HPV vaccine effectiveness against high‐grade cervical lesions has been demonstrated among young Japanese women, but evidence of its effects on invasive cervical cancer (ICC) is lacking. Usin...

Descripción completa

Detalles Bibliográficos
Autores principales: Onuki, Mamiko, Takahashi, Fumiaki, Iwata, Takashi, Nakazawa, Hiroshi, Yahata, Hideaki, Kanao, Hiroyuki, Horie, Koji, Konnai, Katsuyuki, Nio, Ai, Takehara, Kazuhiro, Kamiura, Shoji, Tsuda, Naotake, Takei, Yuji, Shigeta, Shogo, Matsumura, Noriomi, Yoshida, Hiroyuki, Motohara, Takeshi, Yamazaki, Hiroyuki, Nakamura, Keiichiro, Hamanishi, Junzo, Tasaka, Nobutaka, Ishikawa, Mitsuya, Hirashima, Yasuyuki, Kudaka, Wataru, Mori‐Uchino, Mayuyo, Kukimoto, Iwao, Fujii, Takuma, Watanabe, Yoh, Noda, Kiichiro, Yoshikawa, Hiroyuki, Yaegashi, Nobuo, Matsumoto, Koji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
ORIGINAL ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10637081/
https://www.ncbi.nlm.nih.gov/pubmed/37688310
http://dx.doi.org/10.1111/cas.15943

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10637081/
https://www.ncbi.nlm.nih.gov/pubmed/37688310
http://dx.doi.org/10.1111/cas.15943

Ejemplares similares